GlassScriptPhysician profile
Aditya Chopra
NPI 1508850991
$84,862.82
in general payments reported to CMS, 2019-2025
92 companies · $9,229 in 2025
The $9,229 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,461 · 2020: $21K · 2021: $8,729 · 2022: $16K · 2023: $18K · 2024: $8,413 · 2025: $9,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $14K · Education: $161 · Travel and Lodging: $26.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,568.75 |
| Food and Beverage | $13,779.59 |
| Education | $161.27 |
| Travel and Lodging | $26.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $36,169.63 | 2019-2025 | Qulipta, Ubrelvy, Vraylar |
| Allergan, INC. | $18,597.85 | 2019-2021 | |
| Amgen INC. | $4,805.17 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $3,496.06 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $3,290.68 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Biohaven Pharmaceuticals, INC. | $1,720.75 | 2020-2021 | |
| Pfizer INC. | $1,222.35 | 2019-2025 | |
| Novo Nordisk INC | $1,136.36 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $929.63 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $809.03 | 2019-2025 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $760.48 | 2021-2025 | Rexulti |
| Horizon Therapeutics Plc | $641.49 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $615.87 | 2023-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $615.38 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $606.80 | 2021-2025 |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $427.93 | 2024-2025 | Voquezna |
| Biogen, INC. | $415.86 | 2020-2024 | Skyclarys |
| Janssen Pharmaceuticals, INC | $397.25 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $392.62 | 2019-2023 | Livalo, Seglentis |
| Sunovion Pharmaceuticals INC. | $392.02 | 2019-2022 | |
| Esperion Therapeutics, INC. | $377.43 | 2020-2025 | Nexletol, Nexlizet |
| Amarin Pharma, INC. | $374.01 | 2019-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $334.92 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $333.34 | 2019-2025 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $331.16 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $303.81 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Axsome Therapeutics, INC. | $293.82 | 2023-2025 | Auvelity, Symbravo, Sunosi |
| Harmony Biosciences LLC | $293.13 | 2023-2024 | Wakix |
| Acadia Pharmaceuticals INC | $282.70 | 2019-2025 | Nuplazid |
| Corcept Therapeutics | $281.73 | 2024-2025 | Korlym |
| Silk Road Medical, INC. | $255.45 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Corium, LLC | $253.37 | 2022-2024 | Azstarys |
| Idorsia Pharmaceuticals US INC | $209.26 | 2023-2024 | Quviviq |
| Lundbeck LLC | $205.17 | 2023-2025 | Rexulti |
| Abbott Laboratories | $196.87 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Nevro Corp. | $186.22 | 2022-2024 | Senza |
| Teva Pharmaceuticals USA, INC. | $178.89 | 2020-2025 | Austedo Xr |
| Boston Scientific Corporation | $158.67 | 2025 | Enroute Transcarotid Neuroprotection System |
| Eisai INC. | $152.58 | 2020-2024 | |
| Daiichi Sankyo INC. | $133.09 | 2022-2023 | Injectafer |
| Urovant Sciences INC | $124.99 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $123.19 | 2022 | |
| Avanir Pharmaceuticals, INC. | $106.71 | 2019-2022 | |
| Genentech USA, INC. | $101.06 | 2019-2022 | |
| Mylan Specialty L.P. | $100.76 | 2021-2024 | Yupelri |
| Endo Pharmaceuticals INC. | $92.33 | 2020-2021 | |
| Shield Therapeutics INC | $90.01 | 2022-2023 | Accrufer |
| Amneal Pharmaceuticals LLC | $83.01 | 2023 | Lyvispah |
| Verona Pharma, INC. | $74.91 | 2025 | Ohtuvayre |
| Arbor Pharmaceuticals, INC. | $67.56 | 2019-2021 | |
| Medtronic, INC. | $65.85 | 2025 | Endurant Iis |
| Currax Pharmaceuticals LLC | $60.34 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $53.47 | 2025 | Hetlioz, Fanapt |
| Ironwood Pharmaceuticals, INC | $53.13 | 2020-2021 | |
| Optinose US, INC. | $52.58 | 2025 | |
| Aytu Biopharma, INC. | $51.14 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $50.23 | 2019-2022 | |
| Kyowa Kirin, INC. | $50.21 | 2024 | Nourianz |
| Takeda Pharmaceuticals U.S.A., INC. | $49.09 | 2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.65 | 2025 | Caplyta |
| Gilead Sciences, INC. | $45.19 | 2023 | |
| Acorda Therapeutics, INC | $42.76 | 2019 | |
| Lumenis, INC | $42.44 | 2021 | |
| Organogenesis INC. | $42.19 | 2025 | Puraply Wound Matrix |
| Sun Pharmaceutical Industries INC. | $41.99 | 2020-2021 | |
| Genzyme Corporation | $40.73 | 2022 | |
| Hikma Pharmaceuticals USA | $37.28 | 2020-2021 | |
| Digestive Care, INC. | $33.23 | 2024 | Pertzye |
| Tms Neurohealth Centers INC. | $32.36 | 2025 | Tms Neurohealth Centers INC. |
| Circassia INC. | $30.47 | 2019 | |
| Inspire Medical Systems, INC. | $28.69 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $24.57 | 2019 | |
| Medicomp INC | $22.73 | 2024 | Telepatch Cardiac Monitor |
| Phadia US INC. | $22.13 | 2022 | |
| Viatris Specialty LLC | $21.69 | 2025 | Yupelri |
| Jazz Pharmaceuticals INC. | $21.37 | 2022 | |
| Neos Therapeutics, LP | $20.36 | 2021 | |
| Dexcom, INC. | $19.72 | 2024 | Dexcom G6 Transmitter |
| Medtronic Vascular, INC. | $18.59 | 2019 | |
| Ibsa Pharma INC. | $17.96 | 2020 | |
| Eyevance Pharmaceuticals LLC | $17.65 | 2021 | |
| Intercept Pharmaceuticals, INC. | $17.61 | 2020 | |
| Sanofi Pasteur INC. | $17.48 | 2019 | |
| Neurocrine Biosciences, INC. | $17.06 | 2019 | |
| Alexion Pharmaceuticals, INC. | $16.00 | 2024 | Strensiq |
| G Medical Diagnostic Services, INC. | $15.64 | 2022 | |
| Indivior INC. | $14.49 | 2021 | |
| Kaleo, INC. | $13.88 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.83 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $13.78 | 2023 | |
| Nestle Healthcare Nutrition INC. | $11.63 | 2021 | |
| Assertio Therapeutics, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
Qulipta $19KUbrelvy $16KRepatha $1,673Rexulti $917Vraylar $886Enroute Transcarotid Neuroprotection System $670Airsupra $645Nurtec Odt $618Gemtesa $616Breztri $612Trelegy Ellipta $611Voquezna $428Kerendia $397Zavzpret $389Rybelsus $362Ozempic $346Mounjaro $308Farxiga $294Wakix $293Korlym $282Shingrix $266Enroute Transcarotid Stent $255Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter $255Otezla $255Veozah $252Xifaxan $251Jardiance $244Auvelity $243Tezspire $216Arexvy $211Quviviq $209Fasenra $187Comirnaty $170Nexletol $169Eliquis $162Evenity $151Paxlovid $148Austedo Xr $143Nuplazid $137Pertzye $133Prevnar 20 $131Zepbound $130Leqvio $129Capvaxive $128Wegovy $127Prolia $114Abrysvo $112Krystexxa $106Nexlizet $103Entresto $98.26Azstarys $93.78Trulance $87.91Lyvispah $83.01Freestyle Libre 3 $82.67Freestyle Libre 2 $75.45Ohtuvayre $74.91Endurant Iis $65.85Kisunla $55.20Injectafer $54.33Yupelri $54.30Fanapt $53.47Hetlioz $53.47Xhance $52.58Gardasil 9 $50.81Gardasil $50.81Nourianz $50.21Trintellix $49.09Livalo $49.05Seglentis $49.05Caplyta $46.65Puraply Wound Matrix $42.19Botox $38.31Tms Neurohealth Centers INC. $32.36Inspire $28.69Symbravo $27.41Skyclarys $25.22Accrufer $23.93Sunosi $23.82Leqembi $23.42Telepatch Cardiac Monitor $22.73Nucala $21.74Trulicity $20.83Senza $20.20Linzess $19.76Dexcom G6 Transmitter $19.72Boostrix $17.53Amyvid $16.65Strensiq $16.00Myrbetriq $13.93Vascepa $13.00
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.